A federal judge in North Carolina on Tuesday granted an order for summary judgment in favor of Merck (NYSE:MRK) regarding lawsuits accusing the drugmaker of failing to warn consumers its Gardasil shot against HPV could cause two serious conditions.

A federal judge ruled in Merck & Co.’s favor in a safety lawsuit over its Gardasil vaccine, allowing the drugmaker to sidestep more than 200 cases claiming the company concealed safety risks.

At its sprawling complex in Durham, N.C., Merck has opened a new $1 billion, 225,000-square-foot manufacturing plant slated to produce bulk substance for its megablockbuster HPV vaccine Gardasil.

Unveiling of the new factory comes as Merck and other pharma companies face pressure to reshore manufacturing back to the U.S.